On the basis of all the foregoing, the object of this pharmacogenetic study was to evaluate the influence of polymorphisms in functional genes on the survival of anti-TNF and UTK drugs in patients diagnosed with moderate-to-severe psoriasis. This evidence concerns the gene TNF and psoriasis.